The DOI matches its Crossref record; 361 of the 361 references it cites were found in a registry or an index.
Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
Open accessAbstract
Cancer metastasis and therapy resistance are the major unsolved clinical challenges, and account for nearly all cancer‐related deaths. Both metastasis and therapy resistance are fueled by epithelial plasticity, the reversible phenotypic transitions between epithelial and mesenchymal phenotypes, including epithelial‐mesenchymal transition (EMT) and mesenchymal‐epithelial transition (MET). EMT and MET have been largely considered as binary processes, where cells detach from the primary tumor as individual units with many, if not all, traits of a mesenchymal cell (EMT) and then convert back to being epithelial (MET). However, recent studies have demonstrated that cells can metastasize in ways alternative to traditional EMT paradigm; for example, they can detach as clusters, and/or occupy one or more stable hybrid epithelial/mesenchymal (E/M) phenotypes that can be the end point of a transition. Such hybrid E/M cells can integrate various epithelial and mesenchymal traits and markers, facilitating collective cell migration. Furthermore, these hybrid E/M cells may possess higher tumor‐initiation and metastatic potential as compared to cells on either end of the EMT spectrum. Here, we review in silico, in vitro, in vivo and clinical evidence for the existence of one or more hybrid E/M phenotype(s) in multiple carcinomas, and discuss their implications in tumor‐initiation, tumor relapse, therapy resistance, and metastasis. Together, these studies drive the emerging notion that cells in a hybrid E/M phenotype may occupy ‘metastatic sweet spot’ in multiple subtypes of carcinomas, and pathways linked to this (these) hybrid E/M state(s) may be relevant as prognostic biomarkers as well as a promising therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–361 of 361
Tirino, V., Camerlingo, R., Bifulco, K., Irollo, E., Montella, R., Paino, F., Sessa, G., Carriero, M. V., Normanno, N., Rocco, G., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.144 · Cited by 137
Subtypes of Ovarian Cancer and Ovarian Cancer Screening
Koshiyama, M., Matsumura, N., & Konishi, I. (2017) · Diagnostics · doi:10.3390/diagnostics7010012 · Cited by 137
Long non-coding RNA regulation of epithelial–mesenchymal transition in cancer metastasis
Xu, Q., Deng, F., Qin, Y., Zhao, Z., Wu, Z., Xing, Z., Ji, A., & Wang, Q. J. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.149 · Cited by 136
Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition
Chang, H., Liu, Y., Xue, M., Liu, H., Du, S., Zhang, L., & Wang, P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw126 · Cited by 135
The Lymphovascular Embolus of Inflammatory Breast Cancer Expresses a Stem Cell-Like Phenotype
Xiao, Y. Q., Ye, Y., Yearsley, K. H., Jones, S., & Barsky, S. H. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071214 · Cited by 134
Topography of epithelial–mesenchymal plasticity
Font-Clos, F., Zapperi, S., & Porta, C. A. M. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722609115 · Cited by 133
Jensen, D., Dabelsteen, E., Specht, L., Fiehn, A. K., Therkildsen, M. H., Jønson, L., Vikesaa, J., Nielsen, F. C., & von Buchwald, C. (2015) · The Journal of Pathology · doi:10.1002/path.4550 · Cited by 132
Ruscetti, M. A., Dadashian, E. L., Guo, W., Quach, B., Mulholland, D. J., Park, J. W., Tran, L. M., Kobayashi, N., Bianchi-Frias, D., Xing, Y., et al. (2015) · Oncogene · doi:10.1038/onc.2015.444 · Cited by 132
Steinway, S. N., Zañudo, J. G. T., Michel, P., Feith, D. J., Loughran, T. P., & Albert, R. (2015) · npj Systems Biology and Applications · doi:10.1038/npjsba.2015.14 · Cited by 132
Boareto, M., Jolly, M. K., Goldman, A. J., Pietilä, M., Mani, S. A., Sengupta, S., Ben‐Jacob, E., Levine, H., & Onuchic, J. N. (2016) · Journal of The Royal Society Interface · doi:10.1098/rsif.2015.1106 · Cited by 131
Self-citationBistable switches control memory and plasticity in cellular differentiation
Wang, L., Walker, B. L., Iannaccone, S., Bhatt, D., Kennedy, P. J., & Tse, W. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806137106 · Cited by 129
THOMAS, P. A., Kirschmann, D. A., Cerhan, J. R., Folberg, R., Seftor, E. A., Sellers, T. A., & Hendrix, M. J. C. (1999) · PubMed · Cited by 126
Hanrahan, K., O’Neill, A., Prencipe, M., Bugler, J., Murphy, L., Fabre, A., Puhr, M., Čulig, Z., Murphy, K., & Watson, R. W. G. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12030 · Cited by 126
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma
Cammareri, P., Rose, A., Vincent, D. F., Wang, J., Nagano, A., Libertini, S., Ridgway, R. A., Athineos, D., Coates, P. J., McHugh, A. T., et al. (2016) · Nature Communications · doi:10.1038/ncomms12493 · Cited by 125
Jolly, M. K., Kulkarni, P., Weninger, K., Orban, J. P., & Levine, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00050 · Cited by 125
Self-citationShen, X., & Kramer, R. H. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63390-1 · Cited by 124
TGF-β isoforms induce EMT independent migration of ovarian cancer cells
Gao, J., Zhu, Y., Nilsson, M., & Sundfeldt, K. (2014) · Cancer Cell International · doi:10.1186/s12935-014-0072-1 · Cited by 124
OVOL guides the epithelial-hybrid-mesenchymal transition
Jia, D., Jolly, M. K., Boareto, M., Parsana, P., Mooney, S. M., Pienta, K. J., Levine, H., & Ben‐Jacob, E. (2015) · Oncotarget · doi:10.18632/oncotarget.3623 · Cited by 122
Self-citationGonzalez, V. D., Samusik, N., Chen, T. J., Savig, E. S., Aghaeepour, N., Quigley, D. A., Huang, Y.-W., Giangarrà, V., Borowsky, A. D., Hubbard, N. E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.053 · Cited by 122
Cutaneous wound reepithelialization is compromised in mice lacking functional Slug (Snai2)
Hudson, L. G., Newkirk, K. M., Chandler, H. L., Choi, C., Fossey, S. L., Parent, A. E., & Kusewitt, D. F. (2009) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2009.06.009 · Cited by 121
Sharma, A., Paranjape, A. N., Rangarajan, A., & Dighe, R. R. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0508 · Cited by 121
Self-citationAndriani, F., Bertolini, G., Facchinetti, F., Baldoli, E., Moro, M., Casalini, P., Caserini, R., Milione, M., Leone, G., Pelosi, G., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.002 · Cited by 120
Kong, D., Sethi, S. N., Li, Y., Chen, W., Sakr, W., Heath, E. I., & Sarkar, F. H. (2014) · The Prostate · doi:10.1002/pros.22901 · Cited by 119
Inflammatory breast cancer: a model for investigating cluster-based dissemination
Jolly, M. K., Boareto, M., Debeb, B. G., Aceto, N., Farach‐Carson, M. C., Woodward, W. A., & Levine, H. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0023-9 · Cited by 119
Self-citationEpithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
Miow, Q. H., Tan, T. Z., Ye, J., Lau, J. A., Yokomizo, T., Thiery, J.-P., & Mori, S. (2015) · Oncogene · doi:10.1038/onc.2014.136 · Cited by 117
Jagged mediates differences in normal and tumor angiogenesis by affecting tip-stalk fate decision
Boareto, M., Jolly, M. K., Ben‐Jacob, E., & Onuchic, J. N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511814112 · Cited by 117
Self-citationTargeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
Deng, J., Wang, L., Chen, H., Hao, J., Ni, J., Chang, L., Duan, W., Graham, P., & Li, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9908 · Cited by 115
Sub-circuits of a gene regulatory network control a developmental epithelial-mesenchymal transition
Saunders, L. R., & McClay, D. R. (2014) · Development · doi:10.1242/dev.101436 · Cited by 115
Liu, Q., Tong, D., Liu, G., Xu, J., Do, K., Geary, K. R., Zhang, D., Zhang, J., Zhang, Y., Li, Y., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.417 · Cited by 115
Kabashima, A., Higuchi, H., Takaishi, H., Matsuzaki, Y., Suzuki, S., Izumiya, M., Iizuka, H., Sakai, G., Hozawa, S., Azuma, T., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24349 · Cited by 114
Nonsense-Mediated RNA Decay Influences Human Embryonic Stem Cell Fate
Lou, C.-H., Chousal, J. N., Goetz, A. E., Shum, E. Y., Brafman, D. A., Liao, X., Mora-Castilla, S., Ramaiah, M., Cook‐Andersen, H., Laurent, L. C., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.05.008 · Cited by 114
A core matrisome gene signature predicts cancer outcome
Yuzhalin, A. E., Urbonas, T., Silva, M. A., Muschel, R. J., & Gordon-Weeks, A. N. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.458 · Cited by 113
P-cadherin promotes collective cell migration via a Cdc42-mediated increase in mechanical forces
Plutoni, C., Bazellières, E., Borgne, M. L., Comunale, F., Brugués, A., Sevéno, M., Planchon, D., Thuault, S., Morin, N., Bodin, S., et al. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201505105 · Cited by 112
Illuminating breast cancer invasion: diverse roles for cell–cell interactions
Cheung, K. J., & Ewald, A. J. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.07.003 · Cited by 111
Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance
Andugulapati, S. B., Udupa, N., Chamallamudi, M. R., Gupta, V., & Rangarajan, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155013 · Cited by 111
Self-citationHan, J., Fujisawa, T., Husain, S. R., & Puri, R. K. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-173 · Cited by 109
Metformin and Prostate Cancer: a New Role for an Old Drug
Whitburn, J., Edwards, C. M., & Sooriakumaran, P. (2017) · Current Urology Reports · doi:10.1007/s11934-017-0693-8 · Cited by 109
NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer
Belle, V. A., McDermott, N., Meunier, A., & Marignol, L. H. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.195 · Cited by 108
Takai, M., Terai, Y., Kawaguchi, H., Ashihara, K., Fujiwara, S., Tanaka, T., Tsunetoh, S., Tanaka, Y., Sasaki, H., Kanemura, M., et al. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-76 · Cited by 108
Bacterial survival strategies suggest rethinking cancer cooperativity
Ben‐Jacob, E., Coffey, D. S., & Levine, H. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.06.001 · Cited by 106
Self-citationColorectal adenocarcinoma: risks, prevention and diagnosis
Thrumurthy, S. G., Thrumurthy, S. S. D., Gilbert, C. E., Ross, P. J., & Haji, A. (2016) · BMJ · doi:10.1136/bmj.i3590 · Cited by 106
Brozović, A., Durán, G. E., Wang, Y. C., Francisco, E. B., & Sikic, B. I. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.04.015 · Cited by 104
Slug Controls Stem/Progenitor Cell Growth Dynamics during Mammary Gland Morphogenesis
Nassour, M., Idoux‐Gillet, Y., Selmi, A., Côme, C., Faraldo, M. M., Deugnier, M., & Savagner, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053498 · Cited by 104
The Intercellular Metabolic Interplay between Tumor and Immune Cells
Wang, T., Liu, G., & Wang, R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00358 · Cited by 104
MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway
Tripathi, S. C., Fahrmann, J. F., Çeliktaş, M., Aguilar, M., Marini, K. D., Jolly, M. K., Katayama, H., Wang, H., Murage, E. N., Dennison, J. B., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2874 · Cited by 104
Self-citationNumb prevents a complete epithelial–mesenchymal transition by modulating Notch signalling
Bocci, F., Jolly, M. K., Tripathi, S. C., Aguilar, M., Hanash, S., Levine, H., & Onuchic, J. N. (2017) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0512 · Cited by 104
Self-citationExtracellular matrix density promotes EMT by weakening cell–cell adhesions
Kumar, S., Das, A., & Sen, S. (2014) · Molecular BioSystems · doi:10.1039/c3mb70431a · Cited by 103
Yoshida, T., Song, L., Bai, Y., Kinose, F., Li, J., Ohaegbulam, K. C., Muñoz-Antonia, T., Qu, X., Eschrich, S. A., Uramoto, H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147344 · Cited by 103
Ribeiro, A. S., & Paredes, J. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2014.00371 · Cited by 102
Ito, T., Kudoh, S., Ichimura, T., Fujino, K., Hassan, W. A., & Udaka, N. (2016) · Human Cell · doi:10.1007/s13577-016-0149-3 · Cited by 102
Keshamouni, V. G., Jagtap, P. D., Michailidis, G. C., Strahler, J. R., Kuick, R. D., Reka, A. K., Papoulias, P. G., Krishnapuram, R., Srirangam, A., Standiford, T. J., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr8006478 · Cited by 101
Molecular mechanisms controlling the phenotype and the EMT / MET dynamics of hepatocyte
Cicchini, C., Amicone, L., Alonzi, T., Marchetti, A., Mancone, C., & Tripodi, M. (2014) · Liver International · doi:10.1111/liv.12577 · Cited by 100
Sub-Sets of Cancer Stem Cells Differ Intrinsically in Their Patterns of Oxygen Metabolism
Gammon, L., Biddle, A., Heywood, H. K., Johannessen, A. C., & Mackenzie, I. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062493 · Cited by 100
Self-citationRafehi, S., Valdés, Y. R., Bertrand, M., McGee, J., Préfontaine, M., Sugimoto, A. K., DiMattia, G. E., & Shepherd, T. G. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0383 · Cited by 100
Saravanamuthu, S. S., Gao, C., & Zelenka, P. S. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.05.566 · Cited by 99
Phenotypic Plasticity and Cell Fate Decisions in Cancer: Insights from Dynamical Systems Theory
Jia, D., Jolly, M. K., Kulkarni, P., & Levine, H. (2017) · Cancers · doi:10.3390/cancers9070070 · Cited by 99
Self-citationComplex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer
Klymenko, Y., Kim, O., & Stack, M. (2017) · Cancers · doi:10.3390/cancers9080104 · Cited by 99
Probing the Fifty Shades of EMT in Metastasis
Li, W., & Kang, Y. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.01.001 · Cited by 98
Small cell lung cancer: Recruitment of macrophages by circulating tumor cells
Hamilton, G., Rath, B., Klameth, L., & Hochmair, M. J. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1093277 · Cited by 97
The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer
Mooney, S. M., Talebian, V., Jolly, M. K., Jia, D., Gromala, M., Levine, H., & McConkey, B. J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25974 · Cited by 96
Self-citationYamashita, N., Tokunaga, E., Iimori, M., Inoue, Y., Tanaka, K., Kitao, H., Saeki, H., Oki, E., & Maehara, Y. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.02.002 · Cited by 95
Blassl, C., Kuhlmann, J. D., Webers, A., Wimberger, P., Fehm, T. N., & Neubauer, H. J. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.04.002 · Cited by 92
Somarelli, J. A., Shetler, S., Jolly, M. K., Wang, X., DeWitt, S. B., Hish, A. J., Gilja, S., Eward, W. C., Ware, K. E., Levine, H., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00373-16 · Cited by 89
Self-citationChebouti, I., Kasimir‐Bauer, S., Buderath, P., Wimberger, P., Hauch, S., Kimmig, R., & Kuhlmann, J. D. (2017) · Oncotarget · doi:10.18632/oncotarget.16179 · Cited by 89
Chu, K., Boley, K. M., Moraes, R., Barsky, S. H., & Robertson, F. M. (2013) · Oncotarget · doi:10.18632/oncotarget.872 · Cited by 88
van Nes, J. G. H., de Kruijf, E. M., Putter, H., Faratian, D., Munro, A. F., Campbell, F., Smit, V. T. H. B. M., Liefers, G., Kuppen, P. J. K., van de Velde, C. J. �., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1684-y · Cited by 88
Rohnalter, V., Roth, K. S., Finkernagel, F., Adhikary, T., Obert, J., Dorzweiler, K., Bensberg, M., Müller‐Brüsselbach, S., & Müller, R. (2015) · Oncotarget · doi:10.18632/oncotarget.5552 · Cited by 87
Gao, Y., Zhang, Z., Li, K., Gong, L., Yang, Q., Huang, X., Hong, C., Ding, M., & Yang, H. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.311 · Cited by 86
Dang, T. T., Esparza, M. A., Maine, E. A., Westcott, J. M., & Pearson, G. W. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3363 · Cited by 85
Distinguishing mechanisms underlying EMT tristability
Jia, D., Jolly, M. K., Tripathi, S. C., den Hollander, P., Huang, B., Lu, M., Çeliktaş, M., Ramirez‐Peña, E., Ben‐Jacob, E., Onuchic, J. N., et al. (2017) · Cancer Convergence · doi:10.1186/s41236-017-0005-8 · Cited by 84
Self-citationLenferink, A. E. G., Cantin, C., Nantel, A., Wang, E., Durocher, Y., Banville, M., Paul-Roc, B., Marcil, A., Wilson, M. R., & O'Connor-McCourt, M. D. (2010) · Oncogene · doi:10.1038/onc.2009.399 · Cited by 81 · cited 1×
“…and duration of EMT-inducing signals such as TGFβ treatment (Gao, Zhu, Nilsson, & Sundfeldt, 2014; Gregory et al., 2011; Keshamouni et al., 2009; Lenferink et al., 2010; Milano et al., 2016; Tanaka & Ogishima, 2015; Tian et al., 2018; Xu et al., 2018; Zadran, Arumugam, Herschman, Phelps, &…”
BackgroundKim, A., Kwak, J., Je, N. K., Lee, Y.-H., & Jung, Y. (2015) · Toxicological Research · doi:10.5487/tr.2015.31.2.151 · Cited by 80
Carcinosarcomas and Related Cancers: Tumors Caught in the Act of Epithelial-Mesenchymal Transition
Pang, A. S. L., Carbini, M., Moreira, A. L., & Maki, R. G. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.9523 · Cited by 80
Varma, S., Cao, Y., Tagne, J.-B., Lakshminarayanan, M., Li, J., Friedman, T. B., Morell, R. J., Warburton, D., Kotton, D. N., & Ramirez, M. I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.408401 · Cited by 79
Cutaneous Wound Reepithelialization: A Partial and Reversible EMT
Arnoux, V., Côme, C., Kusewitt, D. F., Hudson, L. G., & Savagner, P. (2005) · Springer eBooks · doi:10.1007/0-387-28671-3_8 · Cited by 79
Yin, T., Wei, H., Gou, S., Shi, P., Yang, Z., Zhao, G., & Wang, C. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12031595 · Cited by 79
Bhatia, S., Monkman, J. H., Toh, A. K. L., Nagaraj, S. H., & Thompson, E. W. (2017) · Biochemical Journal · doi:10.1042/bcj20160782 · Cited by 79
Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer
Wang, B., Tang, Z., Gong, H., Zhu, L., & Liu, X. (2017) · Bioscience Reports · doi:10.1042/bsr20171092 · Cited by 78
Zuo, J., Ishikawa, T., Boutros, S., Xiao, Z., Humtsoe, J. O., & Kramer, R. H. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0354 · Cited by 77
Epithelial Phenotype Confers Resistance of Ovarian Cancer Cells to Oncolytic Adenoviruses
Strauss, R., Sova, P., Liu, Y., Li, Z. Y., Tuve, S., Pritchard, D. K., Brinkkoetter, P. T., Möller, T. B., Wildner, O., Pesonen, S. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0645 · Cited by 75
Lateral Induction by Juxtacrine Signaling Is a New Mechanism for Pattern Formation
Owen, M. R., Sherratt, J. A., & Wearing, H. J. (2000) · Developmental Biology · doi:10.1006/dbio.1999.9536 · Cited by 75
Liu, S., Sun, J. P., Cai, B., Xi, X., Yang, L., Zhang, Z., Feng, Y., & Sun, Y. (2016) · Tumor Biology · doi:10.1007/s13277-016-4848-x · Cited by 75
Taube, J. H., Sphyris, N., Johnson, K. S., Reisenauer, K. N., Nesbit, T. A., Joseph, R., Vijay, G. V., Sarkar, T. R., Bhangre, N., Song, J. J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19214 · Cited by 75
Jolly, M. K., Preca, B., Tripathi, S. C., Jia, D., George, J. T., Hanash, S., Brabletz, T., Stemmler, M. P., Maurer, J., & Levine, H. (2018) · APL Bioengineering · doi:10.1063/1.5024874 · Cited by 74
Self-citationSwetha, G., Chandra, V., Phadnis, S. M., & Bhonde, R. R. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00937.x · Cited by 73
The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5
Sundararajan, V., Gengenbacher, N., Stemmler, M. P., Kleemann, J., Brabletz, T., & Brabletz, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4807 · Cited by 72
Roberts, C. M., Tran, M. A., Pitruzzello, M. C., Wen, W. X., Loeza, J., Dellinger, T. H., Mor, G., & Glackin, C. A. (2016) · Scientific Reports · doi:10.1038/srep37652 · Cited by 72
Bocci, F., Jolly, M. K., George, J. T., Levine, H., & Onuchic, J. N. (2018) · Oncotarget · doi:10.18632/oncotarget.25692 · Cited by 72
Self-citationEMT-induced metabolite signature identifies poor clinical outcome
Bhowmik, S. K., Ramirez‐Peña, E., Arnold, J. M., Putluri, V., Sphyris, N., Michailidis, G. C., Putluri, N., Ambs, S., Sreekumar, A., & Mani, S. A. (2015) · Oncotarget · doi:10.18632/oncotarget.4765 · Cited by 71
Ungewiss, C., Rizvi, Z. H., Roybal, J. D., Peng, D. H., Gold, K. A., Shin, D. H., Creighton, C. J., & Gibbons, D. L. (2016) · Scientific Reports · doi:10.1038/srep18652 · Cited by 71
Tian, B., Widen, S. G., Yang, J., Wood, T. G., Kudlicki, A. S., Zhao, Y., & Brasier, A. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003662 · Cited by 71
Shigeishi, H., Biddle, A., Gammon, L., Emich, H., Rodini, C. O., Gemenetzidis, E., Fazil, B., Sugiyama, M., Kamata, N., & Mackenzie, I. C. (2013) · Stem Cells · doi:10.1002/stem.1418 · Cited by 70
Self-citationJolly, M. K., Tripathi, S. C., Somarelli, J. A., Hanash, S., & Levine, H. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12084 · Cited by 70
Self-citationKrohn, A., Ahrens, T. D., Yalcin, A., Plönes, T., Wehrle, J., Taromi, S., Wollner, S., Follo, M., Brabletz, T., Mani, S. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100249 · Cited by 69
Sikandar, S. S., Kuo, A. H., Tomer Kalisky, C., Cai, S., Zabala, M., Hsieh, R. W., Lobo, N. A., Scheeren, F. A., Sim, S., Qian, D., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01666-2 · Cited by 69
Saha, M., Kumar, S., Bukhari, S., Andugulapati, S. B., Kumar, P., Hindupur, S. K., & Rangarajan, A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2090 · Cited by 69
Self-citationTargeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy
Pattabiraman, D. R., & Weinberg, R. A. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030957 · Cited by 69
Nonheritable Cellular Variability Accelerates the Evolutionary Processes of Cancer
Frank, S. A., & Rosner, M. R. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001296 · Cited by 68
Sampson, V. B., David, J. M., Puig, I., Patil, P., de Herreros, A. G., THOMAS, G. V., & Rajasekaran, A. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102041 · Cited by 67
Prislei, S., Martinelli, E., Zannoni, G. F., Petrillo, M., Filippetti, F., Mariani, M., Mozzetti, S., Raspaglio, G., Scambia, G., & Ferlini, C. (2015) · Oncotarget · doi:10.18632/oncotarget.3943 · Cited by 66
Saxena, M. T., Balaji, S. A., Deshpande, N., Ranganathan, S., Pillai, D. M., Hindupur, S. K., & Rangarajan, A. (2018) · Journal of Cell Science · doi:10.1242/jcs.208314 · Cited by 66
Self-citationKlymenko, Y., Johnson, J. K., Bos, B., Lombard, R., Campbell, L., Loughran, E. A., & Stack, M. S. (2017) · Neoplasia · doi:10.1016/j.neo.2017.04.002 · Cited by 65
Lee, A.-F., Chen, M., Chen, C., Yang, C., Huang, M., & Liu, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180383 · Cited by 65
Sulaiman, S. A., Mutalib, N. A., & Jamal, R. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00271 · Cited by 64
Distinct Biological Roles for the Notch Ligands Jagged-1 and Jagged-2
Choi, K. C., Ahn, Y., Gibbons, D. L., Tran, H. T., Creighton, C. J., Girard, L., Minna, J. D., Qin, F. X.-F., & Kurie, J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003111 · Cited by 61
Fustaino, V., Presutti, D., Colombo, T., Cardinali, B., Papoff, G., Brandi, R., Bertolazzi, P., Felici, G., & Ruberti, G. (2017) · Oncotarget · doi:10.18632/oncotarget.21132 · Cited by 60
Zadran, S., Arumugam, R., Herschman, H., Phelps, M. E., & Levine, R. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414714111 · Cited by 59
Bugide, S., Gonugunta, V. K., Penugurti, V., Malisetty, V. L., Vadlamudi, R. K., & Manavathi, B. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0308-2 · Cited by 59
A Collective Route to Head and Neck Cancer Metastasis
Kulasinghe, A., Schmidt, H., Perry, C., Whitfield, B. C. S., Kenny, L., Nelson, C. C., Warkiani, M. E., & Punyadeera, C. (2018) · Scientific Reports · doi:10.1038/s41598-017-19117-9 · Cited by 58
Ware, K. E., Somarelli, J. A., Schaeffer, D., Li, J., Zhang, T., Park, S., Patierno, S. R., Freedman, J. A., Foo, W., García-Blanco, M. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10476 · Cited by 57
Self-citationSUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancer
Viotti, M., WILSON, C. A., McCleland, M. L., Koeppen, H., Haley, B., Jhunjhunwala, S., Klijn, C. N., Modrusan, Z. D., Arnott, D. P., Classon, M., et al. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201705031 · Cited by 55
Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKCζ pathway
Wu, M., Kim, M. R., Chen, Y.-S., Yang, J.-Y., & Chang, C.-J. (2017) · Oncogene · doi:10.1038/onc.2016.467 · Cited by 54
Operating principles of Notch–Delta–Jagged module of cell–cell communication
Jolly, M. K., Boareto, M., Lu, M., Onuchic, J. N., Clementi, C., & Ben‐Jacob, E. (2015) · New Journal of Physics · doi:10.1088/1367-2630/17/5/055021 · Cited by 52
Self-citationGardi, N., Deshpande, T. U., Kamble, S. C., Budhe, S. R., & Bapat, S. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2063 · Cited by 52
Self-citationDetermining Relative Dynamic Stability of Cell States Using Boolean Network Model
Joo, J. I., Zhou, J., Huang, S., & Cho, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-30544-0 · Cited by 52
A Novel Network Profiling Analysis Reveals System Changes in Epithelial-Mesenchymal Transition
Shimamura, T., Imoto, S., Shimada, Y., Hosono, Y., Niida, A., Nagasaki, M., Yamaguchi, R., Takahashi, T., & Miyano, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020804 · Cited by 51
Intermittent Moderate Energy Restriction Improves Weight Loss Efficiency in Diet-Induced Obese Mice
Seimon, R. V., Shi, Y., Slack, K., Lee, K., Fernando, H. A., Nguyen, A., Zhang, L., Lin, S., Enriquez, R. F., Lau, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145157 · Cited by 51
Reprogramming to developmental plasticity in cancer stem cells
O’Brien‐Ball, C., & Biddle, A. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.07.025 · Cited by 51
Self-citationStankevičius, V., Kunigenas, L., Stankunas, E., Kuodyte, K., Strainienė, E., Cicenas, J., Samalavičius, N. E., & Sužiedėlis, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.111 · Cited by 50
Burger, G. A., Danen, E. H. J., & Beltman, J. B. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00162 · Cited by 50
Prometastatic mechanisms of CAF-mediated EMT regulation in pancreatic cancer cells
Shan, T., Chen, S., Chen, X., Lin, W. R., Li, W., Ma, J., Wu, T., Ji, H. L., Li, Y., Cui, X., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3779 · Cited by 49
Byrne, N. M., Nesbitt, H., Ming, L., McKeown, S. R., Worthington, J., & McKenna, D. J. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.29 · Cited by 48
Modeling and characterization of inflammatory breast cancer emboli grown in vitro
Lehman, H. L., Dashner, E. J., Lucey, M., Vermeulen, P. B., Dirix, L. Y., Laere, S. V., & van Golen, K. L. (2012) · International Journal of Cancer · doi:10.1002/ijc.27928 · Cited by 47
Treatment of Concomitant OAB and BPH
Moss, M., Rezan, T., Karaman, U. R., & Gomelsky, A. (2017) · Current Urology Reports · doi:10.1007/s11934-017-0649-z · Cited by 47
Glucose deprivation elicits phenotypic plasticity via ZEB1-mediated expression of NNMT
Kanska, J. E., Aspuria, P.-J. P., Taylor‐Harding, B., Spurka, L., Funari, V. A., Oršulić, S., Karlan, B. Y., & Wiedemeyer, W. R. (2017) · Oncotarget · doi:10.18632/oncotarget.15429 · Cited by 47
Simvastatin interferes with cancer ‘stem-cell’ plasticity reducing metastasis in ovarian cancer
Kato, S., Liberona, M., Cerda‐Infante, J., Sánchez, M., Henríquez, J., Bizama, C., Bravo, M. L. G., González, P., Gejman, R., Brañes, J. A., et al. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0132 · Cited by 47
Harner-Foreman, N., Vadakekolathu, J. N., Laversin, S. A., Mathieu, M. G., Reeder, S., Pockley, A. G., Rees, R. C., & Boocock, D. J. (2017) · Scientific Reports · doi:10.1038/srep40633 · Cited by 46
Zacharias, M., Brčić, L., Eidenhammer, S., & Popper, H. (2018) · BMC Cancer · doi:10.1186/s12885-018-4640-y · Cited by 45
Invasive oral cancer stem cells display resistance to ionising radiation
Gemenetzidis, E., Gammon, L., Biddle, A., Emich, H., & Mackenzie, I. C. (2015) · Oncotarget · doi:10.18632/oncotarget.6268 · Cited by 43
Self-citationShiota, M., Itsumi, M., Takeuchi, A., Imada, K., Yokomizo, A., Kuruma, H., Inokuchi, J., Tatsugami, K., Uchiumi, T., Oda, Y., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0225 · Cited by 43
Distinct routes to metastasis: plasticity-dependent and plasticity-independent pathways
Somarelli, J. A., Schaeffer, D., Marengo, M. S., Bepler, T., Rouse, D. C., Ware, K. E., Hish, A. J., Zhao, Y. C., Buckley, A. F., Epstein, J. I., et al. (2016) · Oncogene · doi:10.1038/onc.2015.497 · Cited by 43
Self-citationMalek, R. A., Wang, H., Taparra, K., & Tran, P. T. (2017) · Cells Tissues Organs · doi:10.1159/000447238 · Cited by 41
May, A., Crawford, B. D., & Nedelcu, A. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00063 · Cited by 40
Strauss, R. A., Li, Z., Liu, Y., Beyer, I., Persson, J., Sova, P., Möller, T., Pesonen, S., Hemminki, A., Hamerlik, P., et al. (2011) · PLoS ONE · doi:10.1371/annotation/8c637352-3614-406c-89dc-e78d10fa069c · Cited by 38
Genomics of Squamous Cell Lung Cancer
Rooney, M., Devarakonda, S. H. K., & Govindan, R. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0063 · Cited by 37
Kai, K., Iwamoto, T., Zhang, D., Shen, L., Takahashi, Y., Rao, A. U. K., Thompson, A. M., Sen, S., & Ueno, N. T. (2018) · Scientific Reports · doi:10.1038/s41598-018-27409-x · Cited by 37
Peart, T. M., Correa, R. J. M., Valdés, Y. R., DiMattia, G. E., & Shepherd, T. G. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9451-3 · Cited by 36
Hiew, M. S. Y., Cheng, H. P., Huang, C.-J., Chong, K., Cheong, S. K., Choo, K., & Kamarul, T. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0461-1 · Cited by 36
Varankar, S., Kamble, S. C., Mali, A. M., More, M., Abraham, A., Kumar, B., Pansare, K., Narayanan, N. J., Sen, A., Dhake, R. D., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz119 · Cited by 33
Self-citationTiran, V., Lindenmann, J., Brčić, L., Heitzer, E., Stanzer, S., Ghaffari‐Tabrizi‐Wizsy, N., Stacher, E., Stoeger, H., Popper, H., Balić, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09929-0 · Cited by 32
Hernandez, J. R., Kim, J. J., Verdone, J. E., Liu, X., Torga, G., Pienta, K. J., & Mooney, S. M. (2015) · Medical Oncology · doi:10.1007/s12032-015-0593-z · Cited by 31
Gould, R. A., Bassen, D. M., Chakrabarti, A., Varner, J. D., & Butcher, J. T. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005251 · Cited by 31
Regulation of epithelial to mesenchymal transition by BRCA1 in breast cancer
Sengodan, S. K., Sreelatha, K. H., Nadhan, R., & Srinivas, P. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.01.008 · Cited by 30
Computational systems biology of epithelial-hybrid-mesenchymal transitions
Jolly, M. K., & Levine, H. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.02.004 · Cited by 25
Self-citationPyMT-1099, a versatile murine cell model for EMT in breast cancer
Saxena, M. T., Kalathur, R. K. R., Neutzner, M., & Christofori, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-30640-1 · Cited by 24
miR-200c dampens cancer cell migration via regulation of protein kinase a subunits
Sigloch, F. C., Burk, U., Biniossek, M. L., Brabletz, T., & Schilling, O. (2015) · Oncotarget · doi:10.18632/oncotarget.4381 · Cited by 23
Salgia, R., Mambetsariev, I., Hewelt, B., Achuthan, S., Li, H., Poroyko, V. A., Wang, Y., & Sattler, M. (2018) · Oncotarget · doi:10.18632/oncotarget.25360 · Cited by 22
Umbreit, C., Flanjak, J., Weiß, C., Erben, P., Aderhold, C., Faber, A., Stern‐Straeter, J., Hoermann, K., & Schultz, J. D. (2014) · PubMed · Cited by 20
Wang, L., Li, P., Hu, W., Xia, Y., Hu, C., Liu, L., & Jiang, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.6301 · Cited by 20
Große-Wilde, A., Kuestner, R. E., Skelton, S. M., MacIntosh, E., d’Hérouël, A. F., Ertaylan, G., del Sol, A., Skupin, A., & Huang, S. (2018) · Oncotarget · doi:10.18632/oncotarget.25034 · Cited by 20
Tanaka, H., & Ogishima, S. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv035 · Cited by 19
Reinforcing targeted therapeutics with phenotypic stability factors
Yaswen, P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.985071 · Cited by 18
Bozzi, F., Brich, S., Dagrada, G. P., Negri, T., Conca, E., Cortelazzi, B., Belfiore, A., Perrone, F., Gualeni, A. V., Gloghini, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12262 · Cited by 18
Numb has distinct function in lung adenocarcinoma and squamous cell carcinoma
Kikuchi, H., Sakakibara‐Konishi, J., Furuta, M., Kikuchi, E., Kikuchi, J., Oizumi, S., Hida, Y., Kaga, K., Kinoshita, I., Dosaka‐Akita, H., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25585 · Cited by 17
Xu, S., Ware, K. E., Ding, Y., Kim, S. Y., Sheth, M. U., Rao, S. R., Chan, W., Armstrong, A. J., Eward, W. C., Jolly, M. K., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020205 · Cited by 17
Self-citationTwist1 induces distinct cell states depending on TGFBR1-activation
Drăgoi, D., Krattenmacher, A., Mishra, V. K., Schmidt, J. M., Kloos, U. J., Meixner, L. K., Hauck, S. M., Buggenthin, F., Schwartz, D., Marr, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8878 · Cited by 16
RNA Binding Proteins Control Transdifferentiation of Hepatic Stellate Cells into Myofibroblasts
Wang, S., Jung, Y., Hyun, J., Friedersdorf, M. B., Oh, S., Kim, J., Premont, R. T., Keene, J. D., & Diehl, A. M. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491987 · Cited by 16
Tripathi, S., Jolly, M. K., Woodward, W. A., Levine, H., & Deem, M. W. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00244 · Cited by 15
Self-citationLi, Y., Liu, T., Ivan, C., Huang, J., Shen, D., Kavanagh, J. J., Bast, R. C., Fu, S., Hu, W., & Sood, A. K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00009 · Cited by 10
Hamilton, G., & Rath, B. (2016) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2016.57 · Cited by 6
Parveen, S., Vedagiri, D., Nair, H. G., Parthasarathy, H., & Harshan, K. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-09179-0 · Cited by 6
Cited by
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032
TGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Usman, S., Waseem, N. H., Nguyen, T. K. N., Mohsin, S., Jamal, A., Teh, M.-T., & Waseem, A. (2021) · Cancers · doi:10.3390/cancers13194985 · Cited by 430
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Wang, Y., Chen, Y., Zhang, J., Yang, Y., Fleishman, J. S., Wang, Y., Wang, J., Chen, J., Li, Y., & Wang, H. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101018 · Cited by 256
Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis
Celià-Terrassa, T., & Jolly, M. K. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036905 · Cited by 163
Self-citation
Metadata
- Authors
- Jolly, M. K., Somarelli, J. A., Sheth, M., Biddle, A., Tripathi, S. C., Armstrong, A. J., Hanash, S. M., Bapat, S. A., Rangarajan, A., & Levine, H.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 194
- Pages
- 161-184
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2894407493
- Cited by
- 333
- References
- 361
- FWCI
- 12.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.